Table 2.
Other malaria treatment type | Trial | Malaria treatment | Dose PQ mg/kg | AUC with PQ days 1 to 15 | AUC without PQ days 1 to 15 | % reduction AUC days 1 to 15 | log(10)AUC with PQ days 1 to 15 | log(10)AUC without PQ days1 to 15 | % reduction log(10)AUC days 1 to 15 |
---|---|---|---|---|---|---|---|---|---|
Non-artemisinin- based | Kolaczinski 2012 | a: CQ | 0.5 | 485.26 | 4266.61 | 88.6 | 2.69 | 3.63 | 26.0 |
Kolaczinski 2012 | b: SP | 0.5 | 924.87 | 5964.77 | 84.5 | 2.97 | 3.78 | 21.4 | |
Artemisinin- based | Shekalaghe 2007 | AS+SP | 0.75 | 40.15 | 65.06 | 38.3 | 1.60 | 1.81 | 11.6 |
Smithuis 2010 | a: AS+AQ | 0.75 | 140.35 | 428.51 | 67.3 | 2.15 | 2.63 | 18.4 | |
Smithuis 2010 | b: AL | 0.75 | 196.24 | 242.86 | 19.2 | 2.29 | 2.39 | 3.9 | |
Smithuis 2010 | c: AS+MQ fixed | 0.75 | 237.78 | 510.03 | 53.4 | 2.38 | 2.71 | 12.2 | |
Smithuis 2010 | d: AS+MQ loose | 0.75 | 183.51 | 293.28 | 37.4 | 2.26 | 2.47 | 8.3 | |
Smithuis 2010 | e: DHAP | 0.75 | 295.24 | 709.60 | 58.4 | 2.47 | 2.85 | 13.4 | |
Sutanto 2013 | DHAP | 0.75 | 1252.48 | 2355.84 | 46.8 | 3.10 | 3.37 | 8.1 | |
Vasquez 2009 | AS+MQ | 0.75 | 500.40 | 305.67 | -63.7 | 2.70 | 2.49 | -8.6 |